Clinical trial collaboration with Pharmacyclics explores novel immuno-oncology combinations

Our partnership with AstraZeneca allows us to explore new and potentially transformational treatment combinations in haematological and solid tumours. Both parties bring deep scientific expertise, and by sharing this we’re expanding treatment options for patients.

Bob Duggan Chairman and Chief Executive Officer, Pharmacyclics